Test-Retest Reliability of the WB6Dim Digital Well-Being Tool: A 3-Day Interval Study
WB6Dim-TRT
Psychometric Validation of Test-Retest Reliability of the WB6Dim Digital Self-Assessment Tool for Well-Being Using a 3-Day Interval Protocol and Contamination Control
1 other identifier
observational
500
1 country
1
Brief Summary
This study aims to establish the test-retest reliability of the WB6Dim digital self-assessment tool across its eight well-being dimensions, using a 3-day interval protocol designed to minimize the probability of genuine well-being changes between assessments. Participants complete the 28-item WB6Dim questionnaire at baseline (T1) and again 3 days later (T2). A single contamination control question at T2 identifies participants who experienced a significant life event during the interval; these pairs are excluded from primary ICC analyses and retained for exploratory analyses. An optional third assessment at 9 weeks (T3) provides preliminary exploratory data on sensitivity to change following access to a well-being program. T3 is not part of the primary design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2026
CompletedStudy Start
First participant enrolled
February 19, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 22, 2026
CompletedFirst Posted
Study publicly available on registry
February 25, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 9, 2026
ExpectedFebruary 25, 2026
February 1, 2026
3 days
February 19, 2026
February 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Test-Retest Reliability (ICC) of the WB6Dim Internal Tension Dimension
ICC(1,1) on contamination-free T1/T2 pairs. Score range: 0 to 1. Higher values indicate greater temporal stability.
Day 0 to Day 3
Test-Retest Reliability (ICC) of the WB6Dim Sleep and Recovery Dimension
ICC(1,1) on contamination-free T1/T2 pairs. Score range: 0 to 1. Higher values indicate greater temporal stability.
Day 0 to Day 3
Test-Retest Reliability (ICC) of the WB6Dim Energy Reservoir Dimension
ICC(1,1) on contamination-free T1/T2 pairs. Score range: 0 to 1. Higher values indicate greater temporal stability.
Day 0 to Day 3
Test-Retest Reliability (ICC) of the WB6Dim Self-Esteem Dimension
ICC(1,1) on contamination-free T1/T2 pairs. Score range: 0 to 1. Higher values indicate greater temporal stability.
Day 0 to Day 3
Test-Retest Reliability (ICC) of the WB6Dim Emotional Climate Dimension
ICC(1,1) on contamination-free T1/T2 pairs. Score range: 0 to 1. Higher values indicate greater temporal stability.
Day 0 to Day 3
Test-Retest Reliability (ICC) of the WB6Dim Cognitive Saturation Dimension
ICC(1,1) on contamination-free T1/T2 pairs. Score range: 0 to 1. Higher values indicate greater temporal stability.
Day 0 to Day 3
Test-Retest Reliability (ICC) of the WB6Dim Hyperconnection Dimension
ICC(1,1) on contamination-free T1/T2 pairs. Score range: 0 to 1.Higher values indicate greater temporal stability.
Day 0 to Day 3
Test-Retest Reliability (ICC) of the WB6Dim Perceived Autonomy Dimension
ICC(1,1) on contamination-free T1/T2 pairs. Score range: 0 to 1. Higher values indicate greater temporal stability.
Day 0 to Day 3
Secondary Outcomes (2)
Contamination Rate at T2
Day 3
ICC Comparison Between Contamination-Free and Contaminated Pairs
Day 0 to Day 3
Other Outcomes (8)
Exploratory Sensitivity to Change - Sleep and Recovery
Day 0 to Week 9
Exploratory Sensitivity to Change - Internal Tension
Day 0 to Week 9
Exploratory Sensitivity to Change - Energy Reservoir
Day 0 to Week 9
- +5 more other outcomes
Study Arms (1)
Cohort C - Test-Retest Reliability
Adult volunteers recruited from a health and well-being newsletter subscriber base. Participants complete the 28-item WB6Dim digital self-assessment at baseline (T1) and again 3 days later (T2). A contamination control question at T2 identifies participants who experienced a significant life event during the interval. An optional third assessment (T3) is completed at 9 weeks by participants who voluntarily accessed a well-being program after T2 completion.
Eligibility Criteria
Adult volunteers recruited from a French health and well-being newsletter subscriber base. Not selected based on medical conditions. Represents the general adult population with an interest in personal well-being and health prevention.
You may qualify if:
- Adults aged 18 years or older
- Able to read and understand French
- Access to an internet-connected device
- Willing to complete the WB6Dim questionnaire at T1 and T2
- Consent to anonymous data collection for research purposes
You may not qualify if:
- Under 18 years of age
- Unable to read or understand French
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Clover Linklead
Study Sites (1)
Clover Link
Bandol, 83150, France
Related Publications (1)
Alitta Q. Validation Study of the WB6Dim Digital Self-Assessment Tool for Well-Being Using Gold-Standard Psychometric Scales. ClinicalTrials.gov NCT07301879. First posted 2025-12-24.
BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Frédérique MD, PhD RETORNAZ, MD, PhD
European Hospital, Unit of Care and Research in Internal Medicine and Infectious Diseases.
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 9 Weeks
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 19, 2026
First Posted
February 25, 2026
Study Start
February 19, 2026
Primary Completion
February 22, 2026
Study Completion (Estimated)
May 9, 2026
Last Updated
February 25, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
13:12All collected data are fully anonymized at the point of entry. No individual-level identifiable data are stored or processed. Participant email addresses are used solely for matching T1 and T2 responses and are not retained after study completion. All analyses are conducted on aggregated, pseudonymized numerical data only. IPD sharing is therefore not applicable.